Sales decline 10.83% to Rs 30.48 crore
Net profit of Jenburkt Pharmaceuticals rose 2.16% to Rs 5.67 crore in the quarter ended September 2020 as against Rs 5.55 crore during the previous quarter ended September 2019. Sales declined 10.83% to Rs 30.48 crore in the quarter ended September 2020 as against Rs 34.18 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales30.4834.18 -11 OPM %23.5221.71 -PBDT8.078.09 0 PBT7.567.55 0 NP5.675.55 2Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
